search

The latest Jewish News

Read this week’s digital edition

Click Here
More issues
Pharmaceutical
CytoReason founder David Harel
November 22, 2022, 1:36 pm
Israeli start-up secured a deal with Pfizer just a year after launch
David Harel, founder of CytoReason, tells the tale of every entrepreneur's dream
By Candice Krieger
Teva facility in Ontario Canada
August 9, 2017, 1:23 pm
‘Substantial drop’ in value of Israeli drugs firm Teva may impact NHS
Experts express worry after major NHS supplier's share price falls by 46 percent in recent days, wiping almost £10 billion off its value
Load More